NOVOSIBIRSK (Sputnik) — Russian scientists are planning to begin clinical trials of the latest boron neutron capture therapy (BNCT), which aims to destroy cancer tumors by a particle accelerator, by 2020, Pavel Lobachev, the director of the Budker Institute of Nuclear Physics, said Monday.
"The task is to renovate the building [for the trials] with the help of The Federal Agency for Scientific Organizations, we [Budker Institute] will do the accelerator, so that we could begin clinical trials by 2020," Lobachev told journalists.
Lobachev expressed hope that BNCT program would launch in 2017 and added that it had united a number of Russian research institutes specializing in chemistry, biology, physics and medicine.
Never miss a story again — sign up to our Telegram channel and we'll keep you up to speed! https://telegram.me/sputniknewsint